Skip to main content

Wal-Zan

Medically reviewed by Drugs.com. Last updated on Jan 4, 2021.

Dosage form: tablet
Ingredients: RANITIDINE HYDROCHLORIDE 150mg
Labeler: Walgreen Company
NDC Code: 0363-0362

Drug Facts

ACTIVE INGREDIENT (IN EACH TABLET)

Ranitidine 150 mg (as ranitidine hydrochloride, USP 168 mg)

PURPOSE

Acid reducer

USES
relieves heartburn associated with acid indigestion and sour stomach
prevents heartburn associated with acid indigestion and sour stomach brought on by certain foods and beverages

WARNINGS

Allergy alert: Do not use if you are allergic to ranitidine or other acid reducers

Do Not Use
if you have trouble or pain swallowing food, vomiting with blood, or bloody or black stools. These may be signs of a serious condition. See your doctor
with other acid reducers
if you have kidney disease, except under the advice and supervision of a doctor

Ask a doctor before use if you have
frequent chest pain
frequent wheezing, particularly with heartburn
unexplained weight loss
nausea or vomiting
stomach pain
had heartburn over 3 months. This may be a sign of a more serious condition.
heartburn with lightheadedness, sweating or dizziness
chest pain or shoulder pain with shortness of breath; sweating; pain spreading to arms, neck or shoulders; or lightheadedness

Stop use and ask a doctor if
your heartburn continues or worsens
you need to take this product for more than 14 days

If pregnant or breast-feeding

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

DIRECTIONS
adults and children 12 years and over:
to relieve symptoms, swallow 1 tablet with a glass of water
to prevent symptoms, swallow 1 tablet with a glass of water 30 to 60 minutes before eating food or drinking beverages that cause heartburn
can be used up to twice daily (do not take more than 2 tablets in 24 hours)
children under 12 years: ask a doctor

OTHER INFORMATION
TAMPER EVIDENT: DO NOT USE IF THE CARTON OR PRINTED FOIL UNDER CAP IS OPEN OR TORN.
store at 20° - 25° C (68° - 77° F)
avoid excessive heat or humidity
this product is sodium and sugar free

INACTIVE INGREDIENTS

colloidal silicon dioxide, croscarmellose sodium, hypromellose, iron oxide red, magnesium stearate, microcrystalline cellulose, polyethylene glycol, talc, titanium dioxide

QUESTIONS?

call 1-800-406-7984

PRINCIPAL DISPLAY PANEL

Well at Walgreens

WALGREENS PHARMACIST RECOMMENDED*

NDC 0363-0362-02

MAXIMUM STRENGTH

Wal-Zan® 150

Ranitidine Tablets, USP 150 mg/Acid Reducer

Prevents & relieves heartburn associated with acid indigestion & sour stomach

200 TABLETS

Compare to Zantac 150® active ingredient‡‡

DISTRIBUTED BY: WALGREEN CO.

5114247/ORG115-F

WAL-ZAN 
ranitidine tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:0363-0362
Route of AdministrationORALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
RANITIDINE HYDROCHLORIDE (RANITIDINE) RANITIDINE150 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE 
CROSCARMELLOSE SODIUM 
HYPROMELLOSES 
FERRIC OXIDE RED 
MAGNESIUM STEARATE 
CELLULOSE, MICROCRYSTALLINE 
POLYETHYLENE GLYCOLS 
TALC 
TITANIUM DIOXIDE 
Product Characteristics
ColorpinkScoreno score
ShapeOVAL (Oval, Shaped) Size12mm
FlavorImprint Code9R
Contains    
Packaging
#Item CodePackage Description
1NDC:0363-0362-231 BOTTLE in 1 CARTON
124 TABLET in 1 BOTTLE
2NDC:0363-0362-501 BOTTLE in 1 CARTON
250 TABLET in 1 BOTTLE
3NDC:0363-0362-951 BOTTLE in 1 CARTON
395 TABLET in 1 BOTTLE
4NDC:0363-0362-521 BOTTLE in 1 BOTTLE
465 TABLET in 1 BOTTLE
5NDC:0363-0362-021 BOTTLE in 1 CARTON
5200 TABLET in 1 BOTTLE
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA20053606/28/2011
Labeler - Walgreen Company (008965063)
Registrant - Ranbaxy Pharmaceuticals Inc (937890044)
Establishment
NameAddressID/FEIOperations
Shasun Pharmaceuticals Limited915786829MANUFACTURE(0363-0362)

 
Walgreen Company

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.